Phillips-Medisize Completes Medical Facility Expansion

Phillips-Medisize Corporation has completed a 33,000 square-foot expansion to its New Richmond, Wis., medical facility.

The New Richmond facility is focused on the manufacturing and assembly of diagnostic and surgical products. The expansion includes additional controlled manufacturing and clean room space.

Phillips-Medisize executives said the expansion is the result of the company’s double-digit growth and increased demand from customers such as Antares Pharma, Inc. and Exact Sciences. The company plans to add a significant number of new technical positions within operations, quality and engineering, along with several production employees at the New Richmond site both this year and early next year.

“We are very excited about the growth that we experience at Phillips-Medisize. Having the right facilities at the right time and place is one of the company’s strategic pillars as well as having the right and most creative employees on staff,” said Matt Jennings, chairman/CEO of Phillips-Medisize Corporation. “We will continue to invest in this business based on our strategic plan that we put into effect more than four years ago.”

Headquartered in Hudson, Wis., Phillips-Medisize is an outsource provider of design and manufacturing services to the drug delivery, consumable diagnostics and medical device, and specialty commercial markets. The company has annual sales of more than $600 million with 80 percent of the total revenue coming from drug delivery, medical device, primary pharmaceutical packaging and diagnostic products such as disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single-use surgical devices and consumable diagnostic components.
 
Phillips-Medisize employs more than 3,400 people in 14 locations throughout the United States, Europe, Mexico and China. The company also has design centers in Wisconsin, California, the Netherlands and China.